Stock Events

Stock Events

Candel Therapeutics (CADL) Q2 2026 Earnings

14MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.37

-0.21

-0.04

0.13

Details

Expected EPS

-0.295842

Actual EPS

-0.14

Surprise EPS

0.16

Surprise Percent

+52.68%

Description

Candel Therapeutics (CADL) has reported earnings of -0.14 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.